inVentiv Health (VTIV) Misses Q3 EPS by 9c
More News related to VTIV
- inVentiv Health Companies Win Seven CLIO Healthcare Awards
- Repros Therapeutics (RPRX) Appoints Jaye Thompson to Board; Other Management Changes
- Repros Appoints Dr. Jaye Thompson to Board of Directors
- inVentiv Health (VTIV) Misses Q3 EPS by 9c
- inVentiv Health Reports Financial Results for Third Quarter 2009
inVentiv Health, Inc. (Nasdaq: VTIV) reports Q3 EPS of $0.34, 9 cents below the analyst estimate of $0.43. Revenue for the quarter was $270.5 million, which compares to the estimate of $300 million.
Related Categories
EarningsStocks Mentioned
-0.11Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
